Under-representation of older adults in pharmacokinetic and pharmacodynamic studies: A solvable problem?

Arduino Mangoni, Paul Jansen, Stephen Jackson

    Research output: Contribution to journalReview articlepeer-review

    14 Citations (Scopus)

    Abstract

    The impact of advancing age, with or without the presence of structural and/or functional organ impairment, on the disposition and effects of drugs, demands adequate representation of older adults in pharmacokinetic and pharmacodynamic studies. Currently, however, this group remains poorly represented both in pre- and post-marketing studies. This review discusses recent data on the participation of older adults in pharmacokinetic/ pharmacodynamic studies using established databases, the potential barriers to study recruitment and retention and possible strategies to enhance participation in this group. The article also provides a critical appraisal of current regulatory documents on the conduct of such studies.

    Original languageEnglish
    Pages (from-to)35-39
    Number of pages5
    JournalExpert Review of Clinical Pharmacology
    Volume6
    Issue number1
    DOIs
    Publication statusPublished - Jan 2013

    Bibliographical note

    Copyright:
    Copyright 2013 Elsevier B.V., All rights reserved.

    Keywords

    • age
    • clinical trials
    • efficacy
    • pharmacodynamics
    • pharmacokinetics
    • safety
    • study design

    Fingerprint Dive into the research topics of 'Under-representation of older adults in pharmacokinetic and pharmacodynamic studies: A solvable problem?'. Together they form a unique fingerprint.

    Cite this